ArticleFrontiers in immunology2025

Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction.

Jing Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.